{
    "ticker": "AORT",
    "name": "Aortech International Limited",
    "description": "Aortech International Limited is a medical technology company specializing in the development of innovative biomaterials and medical devices. Founded in 1997, Aortech focuses on improving patient outcomes through advanced synthetic polymer technologies, particularly in the fields of cardiovascular surgery and other medical applications. The company's flagship product is its unique elastomer material, which is designed to mimic the properties of natural tissue, providing superior performance in medical implants and devices. Aortech's proprietary technology has applications in various sectors, including heart valves, vascular grafts, and other implantable devices. The company is committed to research and development, collaborating with leading medical institutions to enhance the effectiveness and safety of its products. Aortech aims to revolutionize surgical practices by offering solutions that reduce complications and improve recovery times for patients. With a strong emphasis on innovation and quality, Aortech continues to expand its product portfolio and market reach, striving to become a leader in the medical device industry.",
    "industry": [
        "Medical Devices",
        "Biotechnology"
    ],
    "headquarters": "Melbourne, Australia",
    "founded": "1997",
    "website": "https://www.aortech.com.au",
    "ceo": "Dr. Paul McGowan",
    "social_media": {
        "linkedin": "https://www.linkedin.com/company/aortech-international-limited/"
    },
    "investor_relations": "https://www.aortech.com.au/investors",
    "key_executives": [
        {
            "name": "Dr. Paul McGowan",
            "position": "CEO"
        },
        {
            "name": "John Smith",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Medical Devices",
            "products": [
                "Synthetic Heart Valves",
                "Vascular Grafts"
            ]
        },
        {
            "category": "Biomaterials",
            "products": [
                "Elastomeric Polymers"
            ]
        }
    ],
    "seo": {
        "meta_title": "Aortech International Limited | Advanced Medical Technologies",
        "meta_description": "Explore Aortech International Limited, a leader in medical technology specializing in biomaterials and innovative medical devices for cardiovascular surgery.",
        "keywords": [
            "Aortech",
            "Medical Devices",
            "Biomaterials",
            "Cardiovascular Surgery",
            "Synthetic Heart Valves"
        ]
    },
    "faq": [
        {
            "question": "What does Aortech specialize in?",
            "answer": "Aortech specializes in the development of innovative biomaterials and medical devices for cardiovascular applications."
        },
        {
            "question": "Who is the CEO of Aortech?",
            "answer": "Dr. Paul McGowan is the CEO of Aortech International Limited."
        },
        {
            "question": "Where is Aortech headquartered?",
            "answer": "Aortech is headquartered in Melbourne, Australia."
        },
        {
            "question": "What are Aortech's main products?",
            "answer": "Aortech's main products include synthetic heart valves and vascular grafts."
        },
        {
            "question": "When was Aortech founded?",
            "answer": "Aortech was founded in 1997."
        }
    ],
    "competitors": [
        "ABT",
        "MDT",
        "SYK"
    ],
    "related_stocks": [
        "JNJ",
        "BAX",
        "ISRG",
        "ZTS"
    ]
}